Viewing nowOropart 5mg Tablet (Olopatadine Hydrochloride)
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

MFDS item code 200711474 · Notified 2007.10.19 · Insurance code 642702620
Relief of itching associated with allergic rhinitis and skin conditions (eczema, dermatitis, etc.)
This medication is used to relieve itching associated with various skin conditions such as allergic rhinitis, urticaria, eczema or dermatitis, angioedema, pruritus, and psoriasis in adults. It is effective in treating itching caused by allergic rhinitis, urticaria, eczema, and pruritus in children. Thus, this medicine helps to improve the uncomfortable itching caused by allergies and skin diseases.
For adults, the usual oral dose of Olopatadine Hydrochloride is 5mg taken twice daily (in the morning and before bedtime). Dosage may be adjusted according to age and symptoms.
For children aged 10 years and older, an oral dose of Olopatadine Hydrochloride is 5mg taken twice daily (in the morning and before bedtime).
This medication contains lactose, so patients with hereditary diseases that hinder lactose digestion should not take it. Patients with impaired kidney function, elderly individuals, or those with liver dysfunction should use this medication with caution. This medication contains a dye called FD&C Yellow No. 5; those who are allergic to this ingredient should take care. Symptoms such as drowsiness, liver dysfunction, dry mouth, and abdominal pain may occur after taking this medication, so consult a doctor immediately if these symptoms arise. Severe liver issues like hepatitis or jaundice may rarely occur, so liver conditions should be monitored closely. Drowsiness may occur while taking this medication, so it is advisable to avoid driving or operating dangerous machinery. Pregnant women or those who may become pregnant should consult a doctor before taking this medication, and breastfeeding women should avoid taking it or discontinue breastfeeding. The safety of this medication has not been thoroughly established in children, particularly those under 10 years old, so its use is not recommended. Elderly individuals should start with a low dose while closely monitoring their health condition. Taking this medication before allergy tests may affect the test results, so caution is needed. This medication should be kept out of the reach of children, and it should not be transferred to other containers. Additionally, rare cases of myocardial infarction have been reported during the use of this medication, so patients with heart conditions need special attention.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius.
Yellowish-red round film-coated tablet
30 tablets per bottle, 300 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Genupharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.